ArticleBrain & spine2025
Chronic subdural hematoma with mild to moderate symptoms: The effect of initial treatment approach on clinical outcome.
Article in Brain & spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Middle meningeal artery embolization in chronic subdural hematoma: a paradigm shift?European radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The effect of a conservative (wait-and-watch) approach in chronic subdural hematoma (cSDH) patients with mild to moderate symptoms, is poorly studied. Surgical evacuation is effective, but inherently carries the risk of surgical or anesthetic complications. Research question: To assess the effect of conservative or operative (burrhole craniostomy) treatment on clinical outcome, in cSDH patients with mild to moderate symptoms. Methods: This single center, retrospective cohort study included 444 cSDH patients with a Markwalder Grading Scale score 1 or 2, treated between 2012 and 2022. The primary outcomes were complication rate, length of hospital stay and 30-days' mortality. The results were analyzed using both intention-to-treat and as-treated approaches. Propensity score techniques were applied to adjust for clinical and radiological baseline differences. Results: Of the 114 conservatively treated patients, 49 (43%) crossed-over to surgery. The 330 remaining patients were treated surgically. In the intention-to-treat and as-treated analysis, initial surgery was associated with a higher complication rate (OR 2.02, 95% CI 1.04-3.94; OR 2.87, 95% CI 1.04-7.91) and longer hospital stay (β 2.34, 95% CI 0.15-4.52; β 6.62, 95% CI 3.60-9.64). Conservative treatment was associated with higher 30-day mortality (as-treated OR 0.19, 95% CI 0.06-0.66, favoring surgery), but this was unrelated to cSDH. Conclusion: In this selected cohort of cSDH patients with mild to moderate symptoms, a conservative approach was associated with less complications and hospital stay. For these patients, a 'conservative treatment first' regimen may therefore be considered. Corroboration in a prospective cohort with neurological and functional outcomes is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.